Cardiovascular Disease
Studies demonstrate health benefits of mangos, herbs, spices
Recent data suggest that mangos could help improve certain risk factors for chronic disease in patients who are overweight or obese, according to researchers.
Evidence-based therapy for HF less utilized among patients aged at least 80 years
In patients with HF, evidence-based therapy was less utilized among patients aged 80 years and older compared with younger patients, according to new data.
AMPLITUDE-O: Efpeglenatide reduces CV events, CKD progression in high-risk type 2 diabetes
A novel GLP-1 receptor agonist reduced cardiovascular event risk by 27% and kidney disease progression by 32% compared with placebo for high-risk adults with type 2 diabetes, with or without background SGLT2 inhibitor therapy, data show.
VIDEO: Efpeglenatide reduces risk for major adverse CV events in type 2 diabetes
In this video exclusive, Richard E. Pratley, MD, the Samuel E. Crockett chair in diabetes research and medical director of AdventHealth Diabetes Institute, announces results from the AMPLITUDE-O cardiovascular outcomes study of the exendin-based GLP-1 receptor agonist efpeglenatide.
Consistent fruit, vegetable consumption confers lower risks for CVD, all-cause mortality
Snacking on fruit after breakfast, fruit during lunch, vegetables during dinner and dairy after dinner was associated with lower risks for CVD and all-cause mortality, according to new dietary data.
Review highlights need to develop CVD prevention strategies, research in Asia
A new review on systematic studies and analyses highlighted the urgent need for the development of CVD prevention strategies and research to impede CVD epidemics in Asia.
Lipid-lowering therapy use low, LDL elevated in patients with PAD
Among patients with peripheral artery disease, use of lipid-lowering therapies was low and LDL remained elevated, according to findings published in the Journal of the American College of Cardiology.
Race-specific models, machine learning improves HF prediction vs. traditional risk scores
Race-specific machine learning models demonstrated greater prognostic value in the prediction of 10-year HF compared with more traditional, non-race-specific models, according to data published in Circulation.
Decline in CV testing at start of pandemic varied by region
At the beginning of the COVID-19 pandemic, diagnostic CV volumes declined, but the drops varied by U.S. region, according to data from the INCAPS-COVID registry.
Discouraging CVD trends highlight need to ‘stem the tide,’ focus on reducing disparities
Heart disease remains the leading cause of death globally, according to recent statistics, putting the spotlight on prevention and eliminating race and sex disparities.